Resolvyx Pharmaceuticals

... the end in inflammation

Management Team

Resolvyx has brought together a team of dedicated, innovative scientists who bring a broad range of skills and expertise to move forward this ground breaking technology.

Greg Weinhoff
Greg Weinhoff, MD
Executive Chairman
James Nichols
James Nichols, PhD
Chief Operating Officer
and Head of Corporate
Development
Philip J. Vickers
Philip J. Vickers, PhD
Chief Scientific Officer
Per Gjorstrup
Per Gjorstrup, MD PhD
Co-founder and
Chief Medical Officer
C. Eric Schwartz
C. Eric Schwartz, PhD
Vice President of Chemistry

The Resolvin "many-to-one" approach will, for the first time, address the immune system redundancy as a major obstacle to identifying highly efficacious therapies for chronic inflammatory diseases.